Skip to main content
Fig. 2 | Respiratory Research

Fig. 2

From: Benefits of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) in improving lung function and reducing exacerbations in patients with moderate-to-very severe COPD: a pooled analysis of the PINNACLE studies

Fig. 2

Patient disposition (pooled PINNACLE population). Patients were excluded from the pooled population if they did not receive any study treatment or if they had overlapping treatment exposure from enrollment in more than one PINNACLE study (further details are provided in the Methods). FF, formoterol fumarate; GFF, glycopyrrolate/formoterol fumarate; GP, glycopyrrolate; ITT, intent-to-treat; MDI, metered dose inhaler.

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us